Seattle, WA, United States of America

Oliver Press


 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 249(Granted Patents)


Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Oliver Press

Introduction

Oliver Press is a notable inventor based in Seattle, WA, who has made significant contributions to the field of biomedical research. He holds a total of seven patents, showcasing his innovative approach to addressing complex medical challenges. His work primarily focuses on developing advanced therapies for hematological malignancies and related disorders.

Latest Patents

Among his latest patents, one notable invention is the development of bispecific antibodies specifically designed for treating hematological malignancies. This patent outlines compositions and methods for improved pre-targeted radioimmunotherapeutics (PRIT) aimed at treating various hematological disorders, including B cell hyperproliferative disorders and solid tumors. The disclosed compositions feature bispecific antibody compositions that bind to specific antigens, such as CD38 and BCMA, while also binding to a radioactive ligand. The therapeutic methods include administering the bispecific antibody reagent alongside the radioactive ligand, with potential enhancements through additional agents.

Another significant patent involves compositions and methods for CD20 immunotherapy. This invention provides treatments for diseases associated with CD20 expression, utilizing host cells that express fusion proteins, such as anti-CD20 CARs. These treatments may be combined with CD20-specific binding molecules, chemotherapeutics, or inhibitors of immunosuppression components to enhance therapeutic efficacy.

Career Highlights

Oliver Press has had a distinguished career, contributing to the advancement of medical science through his innovative inventions. His work has been instrumental in developing therapies that target specific cancer cells, improving treatment outcomes for patients with hematological malignancies.

Collaborations

Throughout his career, Oliver has collaborated with esteemed colleagues, including Allan Sachs Hoffman and Patrick S Stayton. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

In summary, Oliver Press is a prominent inventor whose work in developing bispecific antibodies and immunotherapy compositions has made a significant impact in the field of biomedical research. His contributions continue to pave the way for advancements in the treatment of hematological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…